Retacrit
My Prescription
Payment
Select pharmacy
$115.15
Print or send this coupon to your phone
AlbertsonsPowered byAbout Retacrit
Drug Details
Epoetin alfa, also known by the brand name Epogen, is an injectable medication designed to treat anemia—a condition marked by low red blood cell count. It is primarily prescribed for patients with chronic kidney disease, those undergoing chemotherapy, or individuals receiving zidovudine for HIV treatment. Additionally, it is used to reduce the necessity for blood transfusions in patients scheduled for specific surgeries with a high risk of blood loss. Epoetin alfa functions as an erythropoiesis-stimulating agent (ESA), mimicking the naturally occurring hormone erythropoietin in the body. This hormone prompts the bone marrow to produce more red blood cells, thereby alleviating anemia. It is important to use this medication under the guidance of a healthcare professional due to potential serious side effects.
Price history for Retacrit
1 Vial, 1ML of 10000UNIT/ML
Average retail price for Retacrit
Average SaveHealth price for Retacrit
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Retacrit dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 1ML of 10000UNIT/ML | 1 Vial | $127.00 | $127.00 |
| 1ML of 2000UNIT/ML | 1 Vial | $30.77 | $30.77 |
| 1ML of 2000UNIT/ML | 2 Vials | $53.53 | $26.77 |
| 1ML of 2000UNIT/ML | 3 Vials | $76.30 | $25.43 |
| 1ML of 3000UNIT/ML | 1 Vial | $42.15 | $42.15 |
| 1ML of 3000UNIT/ML | 2 Vials | $76.30 | $38.15 |
| 1ML of 3000UNIT/ML | 3 Vials | $110.45 | $36.82 |
Retacrit FAQs
Retacrit is used to treat anemia, which is a condition characterized by a deficiency of red blood cells. It is often prescribed for patients with chronic kidney disease, those undergoing chemotherapy, or individuals with certain other medical conditions that lead to anemia. Retacrit works by stimulating the bone marrow to produce more red blood cells, thereby increasing the oxygen-carrying capacity of the blood.
Retacrit and Procrit are both brand names for the drug epoetin alfa, which is used to treat anemia. They are considered biosimilars, meaning Retacrit is highly similar to Procrit in terms of safety, purity, and potency. However, they may have different inactive ingredients or formulations. It is important for patients to follow their healthcare provider's guidance when switching between these medications.
The cost of Retacrit is generally lower compared to Procrit. However, prices can vary based on factors such as location, insurance coverage, and pharmacy. It is advisable for individuals to check with their specific pharmacy or healthcare provider for the most accurate pricing information.
Yes, Retacrit (epoetin alfa-epbx) can cause fatigue as a side effect. It is important for patients to monitor their symptoms and discuss any concerns with their healthcare provider.
Retacrit is not a chemotherapy drug. It is a biosimilar to epoetin alfa, which is used to treat anemia, particularly in patients with chronic kidney disease or those undergoing chemotherapy. It works by stimulating the production of red blood cells.